In particular, we highlight that dynamic changes in pTau217, GFAP, and NfL are associated with cognitive decline and clinical progression and that a substantial proportion of individuals with SCD convert to biomarker positivity over time. The gene discussed is NEFL; the disease is Schnyder corneal dystrophy.